2023 Q4 Form 10-Q Financial Statement

#000010203723000058 Filed on November 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $813.1M $635.8M
YoY Change 2.91% -2.18%
Cost Of Revenue $654.6M $506.8M
YoY Change 0.77% -6.28%
Gross Profit $158.6M $129.0M
YoY Change 12.78% 18.08%
Gross Profit Margin 19.5% 20.3%
Selling, General & Admin $78.56M $73.81M
YoY Change 15.58% 1.98%
% of Gross Profit 49.54% 57.2%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $14.83M $14.26M
YoY Change 1.95% 0.64%
% of Gross Profit 9.35% 11.05%
Operating Expenses $78.56M $73.81M
YoY Change 15.58% 1.98%
Operating Profit $87.46M $55.31M
YoY Change 12.82% 46.0%
Interest Expense $15.53M $17.05M
YoY Change 8.83% 38.98%
% of Operating Profit 17.75% 30.83%
Other Income/Expense, Net $726.0K $728.0K
YoY Change -1152.17% -1045.45%
Pretax Income $75.77M $39.23M
YoY Change 19.11% 50.6%
Income Tax $14.48M $8.439M
% Of Pretax Income 19.11% 21.51%
Net Earnings $53.22M $28.13M
YoY Change 27.74% 28.7%
Net Earnings / Revenue 6.54% 4.42%
Basic Earnings Per Share $2.14 $1.13
Diluted Earnings Per Share $2.12 $1.12
COMMON SHARES
Basic Shares Outstanding 24.56M shares 24.64M shares
Diluted Shares Outstanding 25.06M shares 25.02M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $74.10M $99.68M
YoY Change 3.95% 69.37%
Cash & Equivalents $74.10M $99.68M
Short-Term Investments
Other Short-Term Assets $88.05M $95.63M
YoY Change 10.76% 8.79%
Inventory $1.365B $1.404B
Prepaid Expenses
Receivables $435.3M $368.9M
Other Receivables $33.11M $55.41M
Total Short-Term Assets $2.014B $2.048B
YoY Change 3.16% 2.83%
LONG-TERM ASSETS
Property, Plant & Equipment $360.4M $356.6M
YoY Change 4.17% 4.65%
Goodwill $213.9M $213.9M
YoY Change 0.0% 0.02%
Intangibles $71.70M $74.48M
YoY Change -13.53% -13.53%
Long-Term Investments $75.34M $70.62M
YoY Change 3.82% -0.37%
Other Assets $37.54M $35.34M
YoY Change 15.24% -4.09%
Total Long-Term Assets $820.2M $814.1M
YoY Change 0.89% -1.04%
TOTAL ASSETS
Total Short-Term Assets $2.014B $2.048B
Total Long-Term Assets $820.2M $814.1M
Total Assets $2.834B $2.862B
YoY Change 2.49% 1.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $89.42M $70.90M
YoY Change -57.06% -57.58%
Accrued Expenses $145.0M $157.9M
YoY Change 341.68% 398.32%
Deferred Revenue $19.62M $166.5M
YoY Change 265.7% 1216.87%
Short-Term Debt $365.3M $301.4M
YoY Change 4.96% -48.25%
Long-Term Debt Due $0.00 $0.00
YoY Change
Total Short-Term Liabilities $624.9M $701.1M
YoY Change 4.45% -12.19%
LONG-TERM LIABILITIES
Long-Term Debt $617.2M $617.1M
YoY Change 0.08% 18.92%
Other Long-Term Liabilities $26.61M $15.77M
YoY Change 16.72% 3.05%
Total Long-Term Liabilities $643.8M $632.9M
YoY Change 0.67% 18.46%
TOTAL LIABILITIES
Total Short-Term Liabilities $624.9M $701.1M
Total Long-Term Liabilities $643.8M $632.9M
Total Liabilities $1.375B $1.444B
YoY Change 0.81% -1.03%
SHAREHOLDERS EQUITY
Retained Earnings $1.153B $1.120B
YoY Change 4.53% 3.58%
Common Stock $344.5M $339.2M
YoY Change 2.78% 1.71%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.417B $1.384B
YoY Change
Total Liabilities & Shareholders Equity $2.834B $2.862B
YoY Change 2.49% 1.7%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income $53.22M $28.13M
YoY Change 27.74% 28.7%
Depreciation, Depletion And Amortization $14.83M $14.26M
YoY Change 1.95% 0.64%
Cash From Operating Activities -$57.27M $114.4M
YoY Change -135.27% -194.98%
INVESTING ACTIVITIES
Capital Expenditures $15.10M $14.67M
YoY Change 17.6% -227.37%
Acquisitions
YoY Change
Other Investing Activities $1.219M $4.144M
YoY Change -41.03% 206.51%
Cash From Investing Activities -$13.88M -$10.53M
YoY Change 28.84% 3.54%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 45.13M -84.36M
YoY Change -130.93% -181.34%
NET CHANGE
Cash From Operating Activities -57.27M 114.4M
Cash From Investing Activities -13.88M -10.53M
Cash From Financing Activities 45.13M -84.36M
Net Change In Cash -26.03M 19.54M
YoY Change -554.46% -172.57%
FREE CASH FLOW
Cash From Operating Activities -$57.27M $114.4M
Capital Expenditures $15.10M $14.67M
Free Cash Flow -$72.37M $99.76M
YoY Change -148.39% -191.55%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
2599000 usd
CY2022Q3 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
2599000 usd
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
5845000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
6825000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
4744000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
3448000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
39108000 usd
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
38594000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-2963000 usd
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1869000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
52989000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
349188000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-370000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1957000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
34993000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-22793000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
64855000 usd
CY2022Q3 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
CY2023Q3 us-gaap Severance Costs1
SeveranceCosts1
800000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1079126000 usd
us-gaap Other Operating Income
OtherOperatingIncome
1680000 usd
us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
1080806000 usd
CY2023Q3 uvv Other Contingent Liabilities
OtherContingentLiabilities
1000000 usd
CY2023Q3 us-gaap Stock Repurchase Program Authorized Amount1
StockRepurchaseProgramAuthorizedAmount1
100000000 usd
CY2023Q3 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
95000000 usd
uvv Sales Agreement To Sell Common Stock Of Subsidiary Company Value
SalesAgreementToSellCommonStockOfSubsidiaryCompanyValue
8500000 usd
CY2023Q1 us-gaap Restricted Cash
RestrictedCash
6000000 usd
us-gaap Net Income Loss
NetIncomeLoss
28685000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24774126 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.16
us-gaap Net Income Loss
NetIncomeLoss
28685000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
24774126 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
163365 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
24937491 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.15
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.311
CY2022Q1 us-gaap Goodwill
Goodwill
213998000 usd
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-195000 usd
CY2022Q3 us-gaap Goodwill
Goodwill
213803000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
111608000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
37133000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
74475000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
111539000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
25410000 usd
CY2022Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
86129000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
111621000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
31520000 usd
CY2023Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
80101000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
5613000 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
6345000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
5634000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
11052000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9232000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
8077000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
40480000 usd
CY2023Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
74475000 usd
CY2022Q3 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
14893000 usd
CY2023Q1 us-gaap Derivative Instruments In Hedges Assets At Fair Value
DerivativeInstrumentsInHedgesAssetsAtFairValue
7102000 usd
CY2022Q3 us-gaap Derivative Instruments In Hedges Liabilities At Fair Value
DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
0 usd
CY2023Q1 us-gaap Derivative Instruments In Hedges Liabilities At Fair Value
DerivativeInstrumentsInHedgesLiabilitiesAtFairValue
3967000 usd
CY2022Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
2605000 usd
CY2023Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue
1320000 usd
CY2022Q3 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
181000 usd
CY2023Q1 us-gaap Derivative Instruments Not Designated As Hedging Instruments Liability At Fair Value
DerivativeInstrumentsNotDesignatedAsHedgingInstrumentsLiabilityAtFairValue
435000 usd
CY2023Q3 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
2599000 usd
CY2022Q3 us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
2599000 usd
us-gaap Restructuring Costs And Asset Impairment Charges
RestructuringCostsAndAssetImpairmentCharges
0 usd
CY2023Q3 us-gaap Alternative Investment
AlternativeInvestment
145000 usd
CY2023Q3 us-gaap Trading Securities
TradingSecurities
11238000 usd
CY2023Q3 us-gaap Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
12361000 usd
CY2023Q3 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
1081000 usd
CY2023Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
24825000 usd
CY2023Q3 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
14000 usd
CY2023Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
14000 usd
CY2022Q3 us-gaap Alternative Investment
AlternativeInvestment
334000 usd
CY2022Q3 us-gaap Trading Securities
TradingSecurities
10845000 usd
CY2022Q3 us-gaap Interest Rate Derivative Assets At Fair Value
InterestRateDerivativeAssetsAtFairValue
13959000 usd
CY2022Q3 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
3539000 usd
CY2022Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
28677000 usd
CY2022Q3 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
181000 usd
CY2022Q3 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
181000 usd
CY2023Q1 us-gaap Alternative Investment
AlternativeInvestment
400000 usd
CY2023Q1 us-gaap Trading Securities
TradingSecurities
11698000 usd
CY2023Q1 us-gaap Foreign Currency Contract Asset Fair Value Disclosure
ForeignCurrencyContractAssetFairValueDisclosure
8422000 usd
CY2023Q1 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
20520000 usd
CY2023Q1 us-gaap Interest Rate Derivative Liabilities At Fair Value
InterestRateDerivativeLiabilitiesAtFairValue
3077000 usd
CY2023Q1 us-gaap Foreign Currency Contracts Liability Fair Value Disclosure
ForeignCurrencyContractsLiabilityFairValueDisclosure
1325000 usd
CY2023Q1 us-gaap Liabilities Fair Value Disclosure
LiabilitiesFairValueDisclosure
4402000 usd
us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
700000 usd
CY2023Q3 us-gaap Defined Benefit Plan Expected Future Employer Contributions Remainder Of Fiscal Year
DefinedBenefitPlanExpectedFutureEmployerContributionsRemainderOfFiscalYear
3200000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5700000 usd
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
5300000 usd
uvv Expected Stock Based Compensation For Remaining Current Period
ExpectedStockBasedCompensationForRemainingCurrentPeriod
2900000 usd
us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
1156206000 usd
us-gaap Revenues Excluding Interest And Dividends
RevenuesExcludingInterestAndDividends
1080806000 usd
uvv Equity In Pretax Earnings Of Unconsolidated Affiliates
EquityInPretaxEarningsOfUnconsolidatedAffiliates
-4879000 usd
uvv Equity In Pretax Earnings Of Unconsolidated Affiliates
EquityInPretaxEarningsOfUnconsolidatedAffiliates
-137000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
66347000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
51152000 usd
CY2023Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-74667000 usd
CY2022Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-89606000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1413179000 usd
CY2022Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1360059000 usd
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1373000 usd
CY2022Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
893000 usd
CY2023Q3 uvv Adjustments To Common Stock Accrual Stock Based Compensation
AdjustmentsToCommonStockAccrualStockBasedCompensation
1852000 usd
CY2022Q3 uvv Adjustments To Common Stock Accrual Stock Based Compensation
AdjustmentsToCommonStockAccrualStockBasedCompensation
1622000 usd
CY2023Q3 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
317000 usd
CY2022Q3 us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
291000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
30788000 usd
CY2022Q3 us-gaap Profit Loss
ProfitLoss
19406000 usd
CY2023Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
19647000 usd
CY2022Q3 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
19398000 usd
CY2023Q3 uvv Stock Repurchased And Retired During Period Value Retained Earnings
StockRepurchasedAndRetiredDuringPeriodValueRetainedEarnings
-3371000 usd
CY2022Q3 uvv Stock Repurchased And Retired During Period Value Retained Earnings
StockRepurchasedAndRetiredDuringPeriodValueRetainedEarnings
-2555000 usd
CY2023Q3 uvv Dividend Equivalent Shares Added To Restricted Stock Units Retained Earnings
DividendEquivalentSharesAddedToRestrictedStockUnitsRetainedEarnings
-317000 usd
CY2022Q3 uvv Dividend Equivalent Shares Added To Restricted Stock Units Retained Earnings
DividendEquivalentSharesAddedToRestrictedStockUnitsRetainedEarnings
-291000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-2239000 usd
CY2022Q3 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-1828000 usd
CY2023Q3 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
1681000 usd
CY2022Q3 us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
1680000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1417508000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1354733000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1436952000 usd
CY2022Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1384769000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
1373000 usd
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
893000 usd
uvv Adjustments To Common Stock Accrual Stock Based Compensation
AdjustmentsToCommonStockAccrualStockBasedCompensation
5711000 usd
uvv Adjustments To Common Stock Accrual Stock Based Compensation
AdjustmentsToCommonStockAccrualStockBasedCompensation
5304000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2963000 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2090000 usd
us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
619000 usd
us-gaap Dividends Sharebased Compensation Stock
DividendsSharebasedCompensationStock
557000 usd
us-gaap Profit Loss
ProfitLoss
25627000 usd
us-gaap Profit Loss
ProfitLoss
22207000 usd
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
39357000 usd
us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
38845000 usd
uvv Stock Repurchased And Retired During Period Value Retained Earnings
StockRepurchasedAndRetiredDuringPeriodValueRetainedEarnings
-3371000 usd
uvv Stock Repurchased And Retired During Period Value Retained Earnings
StockRepurchasedAndRetiredDuringPeriodValueRetainedEarnings
-2555000 usd
uvv Dividend Equivalent Shares Added To Restricted Stock Units Retained Earnings
DividendEquivalentSharesAddedToRestrictedStockUnitsRetainedEarnings
-619000 usd
uvv Dividend Equivalent Shares Added To Restricted Stock Units Retained Earnings
DividendEquivalentSharesAddedToRestrictedStockUnitsRetainedEarnings
-557000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
2127000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-5912000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
5845000 usd
us-gaap Payments Of Dividends Minority Interest
PaymentsOfDividendsMinorityInterest
6825000 usd
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
0 usd
us-gaap Minority Interest Decrease From Distributions To Noncontrolling Interest Holders
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
427000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1417508000 usd
CY2022Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1354733000 usd

Files In Submission

Name View Source Status
uvv-20230930_cal.xml Edgar Link unprocessable
R36.htm Edgar Link pending
0000102037-23-000058-index-headers.html Edgar Link pending
0000102037-23-000058-index.html Edgar Link pending
0000102037-23-000058.txt Edgar Link pending
0000102037-23-000058-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
uvv-20230930.htm Edgar Link pending
uvv-20230930.xsd Edgar Link pending
uvv-exhibit311x20230930.htm Edgar Link pending
uvv-exhibit312x20230930.htm Edgar Link pending
uvv-exhibit321x20230930.htm Edgar Link pending
uvv-exhibit322x20230930.htm Edgar Link pending
uvv-20230930_def.xml Edgar Link unprocessable
uvv-20230930_lab.xml Edgar Link unprocessable
uvv-20230930_pre.xml Edgar Link unprocessable
uvv-20230930_htm.xml Edgar Link completed